Signify Health, Inc. SGFY
We take great care to ensure that the data presented and summarized in this overview for Signify Health, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding SGFY
View all-
New Mountain Vantage Advisers, L.L.C. New York, NY140MShares$4.26 Billion44.49% of portfolio
-
Havens Advisors LLC New York, NY29KShares$884,2102.14% of portfolio
-
American Portfolios Advisors Holbrook, NY1.63KShares$49,6980.0% of portfolio
-
Private Capital Group, LLC42Shares$1,2800.0% of portfolio
-
Concourse Financial Group Securities, Inc. Birmingham, AL0Shares$00.0% of portfolio
Latest Institutional Activity in SGFY
Top Purchases
Top Sells
About SGFY
Signify Health, Inc. operates a healthcare platform that utilizes analytics, technology, and healthcare provider networks in the United States. The company operates through Home & Community Services and Episodes of Care Services segments. The Home & Community Services segment offers health evaluations performed within the patient's home or at a healthcare provider facility primarily to Medicare Advantage health plans; diagnostic screening and other ancillary services; and services to address healthcare concerns related to social determinants of health. The Episodes of Care Services segment provides services to enhance the healthcare delivery through developing and managing episodic payment programs in partnership with healthcare providers under the Bundled Payment for Care Improvement Advanced program with Centers for Medicare and Medicaid Services; and care management services. The company serves health plans, governments, employers, health systems, and physician groups. The company operates in Norwalk, Connecticut, New York, New York, Dallas, Texas, South Dakota, Deerfield, Florida, and Rapid City. Signify Health, Inc. was founded in 2017 and is headquartered in Dallas, Texas.
Insider Transactions at SGFY
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 29
2023
|
Josh Builder Chief Technology Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
271,455
-72.08%
|
-
|
Mar 29
2023
|
Josh Builder Chief Technology Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
145,011
-100.0%
|
-
|
Mar 29
2023
|
Josh Builder Chief Technology Officer |
BUY
Conversion of derivative security
|
Direct |
145,011
+34.82%
|
-
|
Mar 29
2023
|
Marc D Rothman Chief Medical Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
189,073
-66.17%
|
-
|
Mar 29
2023
|
Marc D Rothman Chief Medical Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
120,837
-100.0%
|
-
|
Mar 29
2023
|
Marc D Rothman Chief Medical Officer |
BUY
Conversion of derivative security
|
Direct |
120,837
+38.99%
|
-
|
Mar 29
2023
|
Bradford Kyle Armbrester Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
2,304,479
-100.0%
|
-
|
Mar 29
2023
|
Bradford Kyle Armbrester Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
4,068,165
-54.28%
|
-
|
Mar 29
2023
|
Bradford Kyle Armbrester Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
2,304,479
-100.0%
|
-
|
Mar 29
2023
|
Bradford Kyle Armbrester Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
3,686,599
-100.0%
|
-
|
Mar 29
2023
|
Bradford Kyle Armbrester Chief Executive Officer |
BUY
Conversion of derivative security
|
Indirect |
2,304,479
+50.0%
|
-
|
Mar 29
2023
|
Bradford Kyle Armbrester Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
3,686,599
+47.54%
|
-
|
Mar 29
2023
|
Vivian E. Riefberg Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
60,661
-62.09%
|
-
|
Mar 29
2023
|
Vivian E. Riefberg Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
24,173
-100.0%
|
-
|
Mar 29
2023
|
Vivian E. Riefberg Director |
BUY
Conversion of derivative security
|
Direct |
24,173
+28.49%
|
-
|
Mar 29
2023
|
David Pierre Chief Operating Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
972,056
-58.54%
|
-
|
Mar 29
2023
|
David Pierre Chief Operating Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
772,875
-100.0%
|
-
|
Mar 29
2023
|
David Pierre Chief Operating Officer |
BUY
Conversion of derivative security
|
Direct |
772,875
+44.29%
|
-
|
Mar 29
2023
|
Adam Mc Ananey General Counsel and Secretary |
SELL
Sale (or disposition) back to the issuer
|
Direct |
154,199
-77.61%
|
-
|
Mar 29
2023
|
Adam Mc Ananey General Counsel and Secretary |
SELL
Sale (or disposition) back to the issuer
|
Direct |
24,173
-100.0%
|
-
|